Roles for Adenomatous polyposis coli in colon injury prevention and wound healing

腺瘤性大肠杆菌在预防结肠损伤和伤口愈合中的作用

基本信息

  • 批准号:
    10707443
  • 负责人:
  • 金额:
    $ 37.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Over 900,000 Americans are currently diagnosed with Ulcerative colitis (UC), an incurable inflammatory bowel disease of complex etiology. UC is multifactorial, with genetics, microbiota, and uncontrolled immune response leading to recurring colon ulcers and inflammation. With no defined cause, symptom management is critical for patients with this chronic condition. A major endpoint for clinical treatment of UC and other inflammatory bowel diseases is mucosal healing. Current UC therapeutics are predominated by anti- inflammatories. To expand this arsenal, it is important to establish exactly how ulceration prevention and wound healing occur such that these features can be enhanced in a targeted manner. Since our early published discovery that Adenomatous Polyposis Coli (APC) protein has both cytoplasmic and nuclear functions, our research has focused on mechanisms by which nuclear APC maintains normal intestinal homeostasis. To enable our analysis, we generated mice with mutations in APC which compromise nuclear import. These Apc-mNLS mice displayed decreased numbers of mucus-secreting goblet cells (GCs) and increased inflammation, chemokine expression, and tissue damage in response to treatment with the colon irritant DSS compared to their DSS-treated wild-type (WT) littermates. More recently, we published that in WT mice, DSS-treatment could induce a subset of distal colon GCs to express elevated APC levels. Similarly, colon tissue from human CD patients also displayed elevated APC protein level in most GCs, a phenotype not observed in unaffected tissue. Based on these striking results, we wondered whether the elevated APC in UC colon might be a response to ulceration in an attempt to restore normal colonic tissue homeostasis. As such, we sought to determine the mechanistic basis for and cellular consequences of higher APC protein levels in UC tissue. RNA-seq analysis of normal colon cells depleted for APC revealed a set of genes significantly downregulated. Cross-referencing this list with APC ChIP-seq data as well as genes whose expression is altered in UC, we identified 7 genes with roles in wound repair and mucus barrier production that are candidates for transcriptional regulation by nuclear APC. We hypothesize that nuclear APC promotes wound repair and resolution of UC through driving transcription of the major mucus barrier component MUC2 as well as specific wound repair mediators. This hypothesis will be tested by addressing the following questions: Does nuclear APC 1) regulate transcription of modulators of inflammation and wound repair (AIM1)? 2) promote colon wound healing (AIM2)? 3) promote mucus layer generation and thereby impede microbial penetration, alter microbial composition and prevent inflammation (AIM3)? Answering these questions is expected to establish nuclear APC as a key contributor to wound repair, a finding that could ultimately be translated into new therapies for UC and other IBDs.
项目摘要 目前有超过90万美国人被诊断患有溃疡性结肠炎(UC),这是一种无法治愈的炎症性疾病。 病因复杂的肠道疾病。UC是多因素的,遗传学,微生物群和不受控制的免疫 反应导致复发性结肠溃疡和炎症。没有明确的原因,症状管理是 对患有这种慢性疾病的患者至关重要。UC和其他疾病临床治疗的主要终点 炎症性肠病是粘膜愈合。目前的UC治疗主要是抗- 炎症为了扩大这一武库,重要的是要确定究竟如何溃疡预防和伤口 愈合发生,使得这些特征可以以有针对性的方式增强。自从我们的早期出版 发现腺瘤性结肠息肉病(APC)蛋白具有细胞质和细胞核功能,我们 研究集中在核APC维持正常肠内稳态的机制上。使 在我们的分析中,我们产生了具有APC突变的小鼠,该突变损害了核输入。这些Apc-mNLS 小鼠表现出分泌粘液的杯状细胞(GC)数量减少和炎症增加, 趋化因子的表达,以及对结肠刺激剂DSS治疗的反应, DSS处理的野生型(WT)同窝仔。最近,我们发表了在WT小鼠中,DSS治疗可以 诱导远端结肠GC亚组表达升高的APC水平。类似地,来自人CD的结肠组织 在大多数GC中,患者还显示APC蛋白水平升高,这是在未受影响的组织中未观察到的表型。 基于这些惊人的结果,我们想知道UC结肠中APC的升高是否是一种反应, 以恢复正常的结肠组织稳态。因此,我们试图确定 UC组织中较高APC蛋白水平的机制基础和细胞后果。RNA测序分析 耗尽APC的正常结肠细胞显示一组基因显著下调。交叉比对这个 列出APC ChIP-seq数据以及在UC中表达改变的基因,我们鉴定了7个基因, 在创伤修复和粘液屏障产生中的作用,其是通过核APC进行转录调节的候选者。 我们假设核APC通过驱动伤口修复和UC的解决来促进伤口修复和UC的解决。 主要粘液屏障成分MUC 2以及特异性伤口修复介质的转录。 这一假设将通过解决以下问题来检验:核APC 1)调节转录吗 炎症和伤口修复调节剂(AIM 1)?2)促进结肠伤口愈合(AIM 2)?3)促进 粘液层的产生,从而阻止微生物的渗透,改变微生物的组成, 炎症(AIM 3)?解决这些问题有望使核APC成为 伤口修复,这一发现最终可能转化为UC和其他IBD的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTI L NEUFELD其他文献

KRISTI L NEUFELD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISTI L NEUFELD', 18)}}的其他基金

Small molecules modulating RNA-binding protein Msi1
调节 RNA 结合蛋白 Msi1 的小分子
  • 批准号:
    9136068
  • 财政年份:
    2014
  • 资助金额:
    $ 37.15万
  • 项目类别:
Cancer Biology Research Program
癌症生物学研究计划
  • 批准号:
    9975742
  • 财政年份:
    2012
  • 资助金额:
    $ 37.15万
  • 项目类别:
Cancer Biology Program
癌症生物学项目
  • 批准号:
    10671696
  • 财政年份:
    2012
  • 资助金额:
    $ 37.15万
  • 项目类别:
Cancer Biology Program
癌症生物学项目
  • 批准号:
    10493586
  • 财政年份:
    2012
  • 资助金额:
    $ 37.15万
  • 项目类别:
NUCLEAR FUNCTIONS FOR THE TUMOR SUPRESSOR PROTEIN APC
肿瘤抑制蛋白 APC 的核功能
  • 批准号:
    7170251
  • 财政年份:
    2005
  • 资助金额:
    $ 37.15万
  • 项目类别:
Nuclear functions of the tumor suppressor protein APC
肿瘤抑制蛋白APC的核功能
  • 批准号:
    7100157
  • 财政年份:
    2004
  • 资助金额:
    $ 37.15万
  • 项目类别:
NUCLEAR FUNCTIONS FOR THE TUMOR SUPPRESSOR PROTEIN APC
肿瘤抑制蛋白 APC 的核功能
  • 批准号:
    7011661
  • 财政年份:
    2004
  • 资助金额:
    $ 37.15万
  • 项目类别:
Nuclear functions of the tumor suppressor protein APC
肿瘤抑制蛋白APC的核功能
  • 批准号:
    7236715
  • 财政年份:
    2004
  • 资助金额:
    $ 37.15万
  • 项目类别:
Nuclear functions of the tumor suppressor protein APC
肿瘤抑制蛋白APC的核功能
  • 批准号:
    6937753
  • 财政年份:
    2004
  • 资助金额:
    $ 37.15万
  • 项目类别:
Nuclear functions of the tumor suppressor protein APC
肿瘤抑制蛋白APC的核功能
  • 批准号:
    6813737
  • 财政年份:
    2004
  • 资助金额:
    $ 37.15万
  • 项目类别:

相似海外基金

APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    7425971
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    7620114
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    8260721
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    7247167
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    7132974
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and breast cancer: Prevention by curcumin
APC 突变与乳腺癌:姜黄素预防
  • 批准号:
    7813928
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
APC mutation and the initiation of colorectal cancer
APC突变与结直肠癌的发生
  • 批准号:
    nhmrc : 400251
  • 财政年份:
    2006
  • 资助金额:
    $ 37.15万
  • 项目类别:
    NHMRC Project Grants
Development of novel screening method by detection of APC mutation from colorectal cancer cells in stool
开发粪便中结直肠癌细胞APC突变检测新筛查方法
  • 批准号:
    17591404
  • 财政年份:
    2005
  • 资助金额:
    $ 37.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DIETARY INTERACTIONS WITH APC MUTATION IN COLON CANCER
饮食与结肠癌 APC 突变的相互作用
  • 批准号:
    2748805
  • 财政年份:
    1995
  • 资助金额:
    $ 37.15万
  • 项目类别:
DIETARY INTERACTIONS WITH APC MUTATION IN COLON CANCER
饮食与结肠癌 APC 突变的相互作用
  • 批准号:
    2111759
  • 财政年份:
    1995
  • 资助金额:
    $ 37.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了